FCGR3A and prostate neoplasm: In this study, we applied xenograft models Targeted inhibition of FcγRIIIa via siRNA‐mediated knockdown or using inhibitory antibody suppressed growth of primary prostate tumors and reduced distant metastasis in xenograft mouse models.